Navigation Links
Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
Date:2/7/2008

SAN CARLOS, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO) today announced that it will hold the following events in February:

BIO CEO & Investor Conference

February 13, 2008

11:45 a.m. ET

Dr. Ted W. Love, Chairman and CEO
http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=NUVO&item_id=1752425

Fourth Quarter and Year End 2007 Financial Results and Accomplishments

Conference Call & Webcast

February 27, 2008

4:30 p.m. ET (1:30 p.m. PT)

Dr. Ted W. Love, Chairman and CEO

Dr. Michael Levy, EVP, Research and Development

Lee Bendekgey, SVP, Finance and CFO

Dial in: 866-854-8095 domestic and 706-634-8567 international with

passcode 32403438

Replay: 800-642-1687 domestic and 706-645-9291 international with passcode

32403438, available through Wednesday, March 12, 2008

Webcast: This call is being webcast by Thomson/CCBN and can be accessed via Nuvelo's website at http://www.nuvelo.com. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

Live audio webcasts of the events and presentations will also be available online via the Investor Relat
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...aceuticals from Germany and Takeda Pharmaceuticals... cancer drug Matuzumab. Matuzumab is developed by.... Takeda Pharmaceuticals will sign agreement with ...ts from the sale of Matuzumba. Takeda will pay 60 ...
... have found that gene mutation is associated with ...gic amyotrophy (also called HNA) that generally is...re often triggered by an infection, an immunizatio... and shoulders. Nerve inflammation and changes in ...
...ch report made by researchers at Wake Forest Unive...s sustained by workers of the poultry farm are qui...company places on safety. // Researchers had found...es. Almost half of workers reported pain in their ...
...ulation of ages 65 years and above may have a sede...head to be less active//. It is known through earl...ged 65 and above have a regular exercise routine, ...s of independent life. A new UCLA study found that...
Other Medicine News:Health News:Injury Rates High For Workers In Poultry Farms 2
(Date:8/27/2008)...Research Team Makes Crucial Breakthrough in Battle...n,s Disease, CHICAGO, Aug. 27 /- The...nounced that scientists at The University of Notti...le to slow or prevent the onset,of a very common t...earchers have genetically produced the first ever ...
(Date:8/26/2008)...., Aug. 26 /- The Oregon Tourism Comm...ustomer Service Training Program,(Q Care) this wee... is a training program created to support the tour...oyee education. By emphasizing,the importance of q...mployees with tools and resources to better serve ...
(Date:8/26/2008)...s most patients can drive safely six weeks followi...RNewswire-USNewswire/ -- Six weeks following,bunio...hat they are able to,get back behind the wheel of ...issue of The Journal of Bone and Joint Surgery ( h...ake time response in patients who underwent a,firs...
(Date:8/26/2008)... - Coupled with Innovative Manufacturing - Has Pot...emic Preparedness, ROCKVILLE, Md., Aug. 26 /PRNew... announced today favorable results from the second...its pandemic influenza virus-like,particle (VLP) v...ain an,adjuvant, induced robust neutralizing antib...
Breaking Medicine Technology:The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Braking After Bunion Surgery 2Braking After Bunion Surgery 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 2Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 3Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 4Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 5Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program 6Best use for popular CAD assessment procedure is misunderstood 16767 1Best use for popular CAD assessment procedure is misunderstood 16767 2HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call 16764 1HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call 16764 2Cogdell Spencer Inc Announces First Quarter Earnings Release and Conference Call Notice 16761 1Cogdell Spencer Inc Announces First Quarter Earnings Release and Conference Call Notice 16761 2Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 1777 1Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 1777 2Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 1777 3Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 1777 4Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 1777 5
...--Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasd...earch demonstrating a role in chronic inflammatory...protein (HMGB1), a,pro-inflammatory mediator and n...he May 2007 issue of Nature Immunology. The,public...exes that,can stimulate immune cells to produce po...
...April 2007- Biota Holdings,Limited (ASX:BTA) today...bitor (LANI), CS8958, an anti-influenza,treatment,... avian flu virus,H5N1; ,2. completed Phase I studi...ommence comparable studies in the,UK. , ,Biota&rsq...nnounced,that laboratory ,studies had confirmed CS...
Other Medicine Technology:Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5LANI completes Phase I in Japan and to commence Phase I in UK 2LANI completes Phase I in Japan and to commence Phase I in UK 3LANI completes Phase I in Japan and to commence Phase I in UK 4
4 hour identification of over 70 medically important, oxidase-negative, gram-negative bacilli, including E. coli, based on enzyme technology.
Direct antigen rapid immunoassay for the detection of Shiga toxin-producing E. coli 0157, which aids in the diagnosis of E. coli 0157:H7 infection
The Directigen™ Meningitis Individual Tests are presumptive latex slide agglutination tests for the direct qualitative detection of antigens to H. influenzae type b, S. pneumoniae, N. meningitid
...onary new agar plate for economically screening ur...this biplate with the urine specimen. If the infec...mogenic side of the biplate will 3 Since 80-90%...BluEcoli™ Urine Biplate is a fast, easy, and ...
Medicine Products: